What is the Future of PD-1 Inhibitors in Cancer Therapy?
The future of PD-1 inhibitors in cancer therapy looks promising, with ongoing research aimed at enhancing their efficacy and expanding their use. Combination therapies involving PD-1 inhibitors and other modalities such as chemotherapy, radiation, and other immune checkpoint inhibitors are being actively investigated. Additionally, research into biomarkers for predicting response to PD-1 inhibitors is an area of significant interest.
